Radiculocervical spondylopathy
Conditions
Interventions
The control group:The control group
Experimental group:Collateral-clearing pain-removing ointment
Sponsors
Gansu Province second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. It conforms to the western diagnostic criteria of cervical spondylotic radiculopathy; 2. Neck and/or shoulder and back pain were the main clinical manifestations, and the VAS score of single site pain was =4; 3. The medical history of cervical spondylosis was less than 5 years, and the onset of cervical spondylosis was less than 1 week; 4. Aged 18-65, male or female; 5. Junior high school education or above, with more than 1 year experience in using smart phones; 6. Subject gives informed consent and signs relevant documents.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Patients with cervical spondylosis with cervical type, myeloid type, vertebral artery type and sympathetic type as the main symptoms; Always, X-ray /CT/MRI examination showed that the history of cervical spondylosis > 5 years; 2. Other disorders with upper extremity pain, such as neck sprain, thoracic outlet syndrome, tennis elbow, carpal tunnel Syndrome, periarthritis of shoulder, rheumatic myofibrositis, biceps longhead tenosynovitis, etc. 3.1 Patients who had received systematic treatment of cervical spondylosis within weeks, or were using analgesics, non-steroidal anti-inflammatory drugs, Antidepressants or quinolones; 4. Those who have received neck surgery; Cervical vertebra fracture, cervical vertebra congenital malformation, cervical canal osseous stenosis, nerve Periroot inflammation; Complicated with tumor, tuberculosis and other diseases; 5. Liver function (ALT/AST/TBil) exceeds 1.5 times the upper limit of normal value, and renal function Cr exceeds the upper limit of normal value; 6. Have serious primary cardiovascular disease, liver disease, kidney disease, hematologic disease, lung disease or Serious diseases affecting their survival; 7. Patients with cervical spondylosis suitable for surgery (including: 1. Non-surgical treatment of more than 3 to 6 months by regular system is invalid or Non-operative treatment is effective but recurrent and severe symptoms, affecting normal life or workers; 2. Progressive atrophy of the innervated muscles due to radiculopathy; 3. Patients with obvious symptoms of nerve root tingling, acute and severe pain, seriously affecting sleep and normal life), or those who plan to receive surgical treatment; 8. Neck damage or abnormal skin (such as rash, eczema, etc.), allergic skin; 9. Women who are breast-feeding, pregnant or planning pregnancy within six months; 10. People who have a history of drug allergy, or allergic constitution (allergic to more than 2 kinds of substances). Always, Asthma, urticaria or anaphylaxis after taking aspirin or other nsaids; 11. Those who have participated in other clinical trials within 3 months after consultation; 12. Those with conditions considered unsuitable for the study, such as a long history of alcohol consumption.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale of pain; | — |
Countries
China
Contacts
Public Contactxiexingwen
Gansu Province second People's Hospital
Outcome results
None listed